Risk of congenital cytomegalovirus infection among HIV-exposed uninfected infants is not decreased by maternal nelfinavir use during pregnancy. [electronic resource]
Producer: 20161214Description: 1051-8 p. digitalISSN:- 1096-9071
- Adult
- CD4-Positive T-Lymphocytes -- immunology
- Cohort Studies
- Cytomegalovirus -- genetics
- Cytomegalovirus Infections -- congenital
- DNA, Viral -- blood
- Female
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- therapeutic use
- Humans
- Infant, Newborn
- Infectious Disease Transmission, Vertical -- prevention & control
- Mothers
- Nelfinavir -- adverse effects
- Pregnancy
- Pregnancy Complications, Infectious -- drug therapy
- Prevalence
- Risk Factors
- Young Adult
No physical items for this record
Publication Type: Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.